← Leaderboards
Kristi Egland
University Of South Dakota
$678,824
Attributed
$678,824
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $146.9K · FY2005–09$200K$150K$100K$50K$0
'05
'06
'07
'08
'09
Funding mix
By agency
NIH$678,824 · 1
By mechanism
P20$678,824 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of South Dakota
Same institution · by research overlap
- Barbara E Goodman$18,114,520
- Amy J Elliott$69,850,347
- Gerald John Yutrzenka$6,112,805
- Brian Donald Burrell$3,333,254
- Eduardo A. Callegari$4,170,554
Others in their field
Top investigators on “Liver”
- David Heimbrook · Leidos Biomedical Research, Inc.$183,557,534
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Richard Douglas Moore · Johns Hopkins University$59,048,354
- Paul M. Ridker · Brigham And Women'S Hospital$55,416,022
- Michael S. Saag · University Of Alabama At Birmingham$50,288,385
- Mark A Kay · Stanford University$49,905,067
Research focus
LiverKidneyBrainAmino Acid SequenceBaseBreast Cancer CellBreast Cancer Early DetectionCancer Cell LineBrca1 GeneCancer PatientCdna LibraryBrca2 GeneDiagnosisDiagnosticEarly DiagnosisErbb2 GeneEstrogen ReceptorsFemaleFoundationsFrequencies (Time Pattern)FutureGenesHousekeepingLung
Grant awards (5)
Characterizing BASE and HER2 for use as tumor markers for breast cancer$143,933
P20 · FY2009 · MD · contact PI
Characterizing BASE and HER2 for use as tumor markers for breast cancer$146,860
P20 · FY2008 · MD · contact PI
Characterizing BASE and HER2 for use as tumor markers for breast cancer$137,906
P20 · FY2007 · MD · contact PI
BASE and HER2 for use as tumor markers for breast cancer$120,000
P20 · FY2006 · MD · contact PI
BASE and HER2 for use as tumor markers for breast cancer$130,125
P20 · FY2005 · MD